nodes	percent_of_prediction	percent_of_DWPC	metapath
Pranlukast—IL5—Glucocorticoid receptor regulatory network—POU1F1—hypothyroidism	0.056	0.108	CbGpPWpGaD
Pranlukast—IL5—Hematopoietic Stem Cell Differentiation—TPO—hypothyroidism	0.0457	0.0883	CbGpPWpGaD
Pranlukast—RNASE3—blood—hypothyroidism	0.035	0.0724	CbGeAlD
Pranlukast—IL5—blood—hypothyroidism	0.0318	0.0658	CbGeAlD
Pranlukast—MUC2—gonad—hypothyroidism	0.028	0.058	CbGeAlD
Pranlukast—IL5—testis—hypothyroidism	0.0263	0.0544	CbGeAlD
Pranlukast—TNF—blood—hypothyroidism	0.0244	0.0506	CbGeAlD
Pranlukast—TNF—Amyotrophic lateral sclerosis (ALS)—NEFH—hypothyroidism	0.0243	0.047	CbGpPWpGaD
Pranlukast—MUC2—female gonad—hypothyroidism	0.0228	0.0472	CbGeAlD
Pranlukast—NFKB1—Glucocorticoid receptor regulatory network—POU1F1—hypothyroidism	0.0228	0.044	CbGpPWpGaD
Pranlukast—TNF—RXR and RAR heterodimerization with other nuclear receptor—THRA—hypothyroidism	0.0212	0.0411	CbGpPWpGaD
Pranlukast—TNF—Amyotrophic lateral sclerosis (ALS)—NEFM—hypothyroidism	0.0207	0.04	CbGpPWpGaD
Pranlukast—MUC2—testis—hypothyroidism	0.0202	0.0418	CbGeAlD
Pranlukast—IL5—Regulation of nuclear SMAD2/3 signaling—NKX2-5—hypothyroidism	0.0197	0.0381	CbGpPWpGaD
Pranlukast—MUC2—liver—hypothyroidism	0.0191	0.0395	CbGeAlD
Pranlukast—CYP2C9—urine—hypothyroidism	0.019	0.0394	CbGeAlD
Pranlukast—NFKB1—heart—hypothyroidism	0.0187	0.0386	CbGeAlD
Pranlukast—MUC2—cerebellum—hypothyroidism	0.0187	0.0386	CbGeAlD
Pranlukast—NFKB1—cardiovascular system—hypothyroidism	0.0176	0.0365	CbGeAlD
Pranlukast—TNF—EV release from cardiac cells and their functional effects—PRL—hypothyroidism	0.0175	0.0338	CbGpPWpGaD
Pranlukast—NFKB1—gonad—hypothyroidism	0.016	0.0331	CbGeAlD
Pranlukast—NFKB1—pituitary gland—hypothyroidism	0.0156	0.0323	CbGeAlD
Pranlukast—TNF—Monoamine Transport—SLC5A7—hypothyroidism	0.0147	0.0283	CbGpPWpGaD
Pranlukast—CYP3A4—urine—hypothyroidism	0.0145	0.0301	CbGeAlD
Pranlukast—NFKB1—adrenal gland—hypothyroidism	0.0139	0.0288	CbGeAlD
Pranlukast—NFKB1—blood—hypothyroidism	0.0139	0.0288	CbGeAlD
Pranlukast—TNF—RXR and RAR heterodimerization with other nuclear receptor—THRB—hypothyroidism	0.0137	0.0265	CbGpPWpGaD
Pranlukast—CYSLTR1—adrenal gland—hypothyroidism	0.0137	0.0283	CbGeAlD
Pranlukast—CYSLTR1—blood—hypothyroidism	0.0137	0.0283	CbGeAlD
Pranlukast—NFKB1—thyroid gland—hypothyroidism	0.0134	0.0278	CbGeAlD
Pranlukast—NFKB1—female gonad—hypothyroidism	0.013	0.0269	CbGeAlD
Pranlukast—NFKB1—testis—hypothyroidism	0.0115	0.0239	CbGeAlD
Pranlukast—IL5—GPVI-mediated activation cascade—VAV3—hypothyroidism	0.011	0.0213	CbGpPWpGaD
Pranlukast—NFKB1—liver—hypothyroidism	0.0109	0.0225	CbGeAlD
Pranlukast—IL5—Glucocorticoid receptor regulatory network—BGLAP—hypothyroidism	0.0107	0.0207	CbGpPWpGaD
Pranlukast—NFKB1—cerebellum—hypothyroidism	0.0106	0.022	CbGeAlD
Pranlukast—NFKB1—EPO signaling pathway—SH2B3—hypothyroidism	0.00916	0.0177	CbGpPWpGaD
Pranlukast—TNF—Amyotrophic lateral sclerosis (ALS)—NEFL—hypothyroidism	0.00823	0.0159	CbGpPWpGaD
Pranlukast—IL5—Glucocorticoid receptor regulatory network—PRL—hypothyroidism	0.00788	0.0152	CbGpPWpGaD
Pranlukast—NFKB1—SIDS Susceptibility Pathways—DLX2—hypothyroidism	0.00665	0.0129	CbGpPWpGaD
Pranlukast—NFKB1—Osteopontin-mediated events—VAV3—hypothyroidism	0.00645	0.0125	CbGpPWpGaD
Pranlukast—ABCC2—adrenal gland—hypothyroidism	0.00547	0.0113	CbGeAlD
Pranlukast—ABCC2—blood—hypothyroidism	0.00547	0.0113	CbGeAlD
Pranlukast—TNF—SIDS Susceptibility Pathways—DLX2—hypothyroidism	0.00506	0.00979	CbGpPWpGaD
Pranlukast—CYSLTR1—G alpha (q) signalling events—TRH—hypothyroidism	0.00496	0.00959	CbGpPWpGaD
Pranlukast—CYP2C9—heart—hypothyroidism	0.00488	0.0101	CbGeAlD
Pranlukast—IL5—Glucocorticoid receptor regulatory network—POMC—hypothyroidism	0.00466	0.00902	CbGpPWpGaD
Pranlukast—CYP2C9—cardiovascular system—hypothyroidism	0.00461	0.00954	CbGeAlD
Pranlukast—ABCC2—testis—hypothyroidism	0.00452	0.00936	CbGeAlD
Pranlukast—CYSLTR1—Gastrin-CREB signalling pathway via PKC and MAPK—TRH—hypothyroidism	0.00444	0.00858	CbGpPWpGaD
Pranlukast—NFKB1—Glucocorticoid receptor regulatory network—BGLAP—hypothyroidism	0.00434	0.00839	CbGpPWpGaD
Pranlukast—NFKB1—SIDS Susceptibility Pathways—THRB—hypothyroidism	0.00428	0.00828	CbGpPWpGaD
Pranlukast—ABCC2—liver—hypothyroidism	0.00427	0.00885	CbGeAlD
Pranlukast—NFKB1—Apoptosis-related network due to altered Notch3 in ovarian cancer—VAV3—hypothyroidism	0.0042	0.00812	CbGpPWpGaD
Pranlukast—MUC2—Metabolism of proteins—TSHB—hypothyroidism	0.00409	0.00791	CbGpPWpGaD
Pranlukast—ABCC2—NRF2 pathway—SLC5A7—hypothyroidism	0.00406	0.00785	CbGpPWpGaD
Pranlukast—NFKB1—TCR Signaling Pathway—SH2B3—hypothyroidism	0.004	0.00774	CbGpPWpGaD
Pranlukast—CYP2C9—blood—hypothyroidism	0.00364	0.00754	CbGeAlD
Pranlukast—NFKB1—DNA Damage Response (only ATM dependent)—PIK3C2A—hypothyroidism	0.00344	0.00664	CbGpPWpGaD
Pranlukast—IL5—Platelet activation, signaling and aggregation—VAV3—hypothyroidism	0.0033	0.00637	CbGpPWpGaD
Pranlukast—CYSLTR1—Class A/1 (Rhodopsin-like receptors)—TRH—hypothyroidism	0.00328	0.00635	CbGpPWpGaD
Pranlukast—TNF—SIDS Susceptibility Pathways—THRB—hypothyroidism	0.00326	0.00631	CbGpPWpGaD
Pranlukast—NFKB1—Glucocorticoid receptor regulatory network—PRL—hypothyroidism	0.0032	0.00619	CbGpPWpGaD
Pranlukast—TNF—Apoptosis-related network due to altered Notch3 in ovarian cancer—VAV3—hypothyroidism	0.0032	0.00618	CbGpPWpGaD
Pranlukast—NFKB1—p75 NTR receptor-mediated signalling—VAV3—hypothyroidism	0.00296	0.00573	CbGpPWpGaD
Pranlukast—IL5—Cytokine Signaling in Immune system—PRL—hypothyroidism	0.00295	0.0057	CbGpPWpGaD
Pranlukast—CYSLTR1—Class A/1 (Rhodopsin-like receptors)—TSHR—hypothyroidism	0.00293	0.00566	CbGpPWpGaD
Pranlukast—CYSLTR1—Class A/1 (Rhodopsin-like receptors)—TSHB—hypothyroidism	0.00293	0.00566	CbGpPWpGaD
Pranlukast—CYP2C9—liver—hypothyroidism	0.00285	0.0059	CbGeAlD
Pranlukast—NFKB1—Ceramide signaling pathway—IGF1—hypothyroidism	0.0028	0.00541	CbGpPWpGaD
Pranlukast—CYP3A4—blood—hypothyroidism	0.00278	0.00575	CbGeAlD
Pranlukast—NFKB1—TCR Signaling Pathway—VAV3—hypothyroidism	0.00275	0.00531	CbGpPWpGaD
Pranlukast—CYSLTR1—G alpha (q) signalling events—AVP—hypothyroidism	0.00261	0.00504	CbGpPWpGaD
Pranlukast—NFKB1—Cardiac Hypertrophic Response—IGF1—hypothyroidism	0.00251	0.00485	CbGpPWpGaD
Pranlukast—CYSLTR1—GPCR ligand binding—TRH—hypothyroidism	0.0025	0.00484	CbGpPWpGaD
Pranlukast—IL5—Hemostasis—SH2B3—hypothyroidism	0.00248	0.00479	CbGpPWpGaD
Pranlukast—CYSLTR1—Gastrin-CREB signalling pathway via PKC and MAPK—AVP—hypothyroidism	0.00233	0.00451	CbGpPWpGaD
Pranlukast—CYSLTR1—GPCR ligand binding—TSHB—hypothyroidism	0.00223	0.00431	CbGpPWpGaD
Pranlukast—CYSLTR1—GPCR ligand binding—TSHR—hypothyroidism	0.00223	0.00431	CbGpPWpGaD
Pranlukast—CYP3A4—liver—hypothyroidism	0.00217	0.0045	CbGeAlD
Pranlukast—TNF—Ceramide signaling pathway—IGF1—hypothyroidism	0.00213	0.00412	CbGpPWpGaD
Pranlukast—IL5—Platelet activation, signaling and aggregation—IGF1—hypothyroidism	0.00203	0.00393	CbGpPWpGaD
Pranlukast—IL5—GPCR downstream signaling—TRH—hypothyroidism	0.00197	0.00381	CbGpPWpGaD
Pranlukast—TNF—Cardiac Hypertrophic Response—IGF1—hypothyroidism	0.00191	0.0037	CbGpPWpGaD
Pranlukast—NFKB1—Glucocorticoid receptor regulatory network—POMC—hypothyroidism	0.0019	0.00367	CbGpPWpGaD
Pranlukast—IL5—Immune System—CLTC—hypothyroidism	0.00189	0.00366	CbGpPWpGaD
Pranlukast—NFKB1—BDNF signaling pathway—VAV3—hypothyroidism	0.00189	0.00365	CbGpPWpGaD
Pranlukast—NFKB1—Apoptosis—IGF1—hypothyroidism	0.00179	0.00346	CbGpPWpGaD
Pranlukast—NFKB1—MicroRNAs in cardiomyocyte hypertrophy—IGF1—hypothyroidism	0.00179	0.00346	CbGpPWpGaD
Pranlukast—IL5—Signaling by GPCR—TRH—hypothyroidism	0.00179	0.00346	CbGpPWpGaD
Pranlukast—IL5—GPCR downstream signaling—TSHB—hypothyroidism	0.00176	0.00339	CbGpPWpGaD
Pranlukast—IL5—GPCR downstream signaling—TSHR—hypothyroidism	0.00176	0.00339	CbGpPWpGaD
Pranlukast—NFKB1—Corticotropin-releasing hormone—POMC—hypothyroidism	0.00173	0.00334	CbGpPWpGaD
Pranlukast—CYSLTR1—Class A/1 (Rhodopsin-like receptors)—AVP—hypothyroidism	0.00173	0.00334	CbGpPWpGaD
Pranlukast—NFKB1—SIDS Susceptibility Pathways—AVP—hypothyroidism	0.00171	0.0033	CbGpPWpGaD
Pranlukast—IL5—Hemostasis—VAV3—hypothyroidism	0.0017	0.00329	CbGpPWpGaD
Pranlukast—ABCC2—NRF2 pathway—SLC5A5—hypothyroidism	0.00162	0.00314	CbGpPWpGaD
Pranlukast—MUC2—Metabolism of proteins—POMC—hypothyroidism	0.0016	0.0031	CbGpPWpGaD
Pranlukast—NFKB1—Fc epsilon receptor (FCERI) signaling—VAV3—hypothyroidism	0.0016	0.00309	CbGpPWpGaD
Pranlukast—IL5—Signaling by GPCR—TSHB—hypothyroidism	0.00159	0.00308	CbGpPWpGaD
Pranlukast—IL5—Signaling by GPCR—TSHR—hypothyroidism	0.00159	0.00308	CbGpPWpGaD
Pranlukast—MUC2—Metabolism of proteins—IGF1—hypothyroidism	0.00154	0.00298	CbGpPWpGaD
Pranlukast—NFKB1—Developmental Biology—CLTC—hypothyroidism	0.00149	0.00289	CbGpPWpGaD
Pranlukast—CYSLTR1—GPCR downstream signaling—TRH—hypothyroidism	0.00141	0.00273	CbGpPWpGaD
Pranlukast—TNF—Apoptosis—IGF1—hypothyroidism	0.00136	0.00263	CbGpPWpGaD
Pranlukast—TNF—MicroRNAs in cardiomyocyte hypertrophy—IGF1—hypothyroidism	0.00136	0.00263	CbGpPWpGaD
Pranlukast—CYSLTR1—GPCR ligand binding—AVP—hypothyroidism	0.00131	0.00254	CbGpPWpGaD
Pranlukast—ABCC2—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.0013	0.00251	CbGpPWpGaD
Pranlukast—TNF—SIDS Susceptibility Pathways—AVP—hypothyroidism	0.0013	0.00251	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling by GPCR—TRH—hypothyroidism	0.00128	0.00248	CbGpPWpGaD
Pranlukast—NFKB1—Adaptive Immune System—CLTC—hypothyroidism	0.00127	0.00245	CbGpPWpGaD
Pranlukast—CYSLTR1—GPCR downstream signaling—TSHR—hypothyroidism	0.00126	0.00244	CbGpPWpGaD
Pranlukast—CYSLTR1—GPCR downstream signaling—TSHB—hypothyroidism	0.00126	0.00244	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—CLTC—hypothyroidism	0.00122	0.00236	CbGpPWpGaD
Pranlukast—NFKB1—Cytokine Signaling in Immune system—PRL—hypothyroidism	0.0012	0.00232	CbGpPWpGaD
Pranlukast—CYSLTR1—Class A/1 (Rhodopsin-like receptors)—POMC—hypothyroidism	0.00115	0.00222	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling by GPCR—TSHB—hypothyroidism	0.00114	0.00221	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling by GPCR—TSHR—hypothyroidism	0.00114	0.00221	CbGpPWpGaD
Pranlukast—TNF—Developmental Biology—CLTC—hypothyroidism	0.00114	0.0022	CbGpPWpGaD
Pranlukast—NFKB1—Signaling by NGF—VAV3—hypothyroidism	0.00109	0.00211	CbGpPWpGaD
Pranlukast—ABCC2—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	0.00108	0.00208	CbGpPWpGaD
Pranlukast—IL5—GPCR downstream signaling—VAV3—hypothyroidism	0.00107	0.00208	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—TRH—hypothyroidism	0.00106	0.00204	CbGpPWpGaD
Pranlukast—IL5—Hemostasis—IGF1—hypothyroidism	0.00105	0.00202	CbGpPWpGaD
Pranlukast—IL5—GPCR downstream signaling—AVP—hypothyroidism	0.00103	0.002	CbGpPWpGaD
Pranlukast—IL5—Signaling by GPCR—VAV3—hypothyroidism	0.000975	0.00189	CbGpPWpGaD
Pranlukast—IL5—Immune System—PRL—hypothyroidism	0.000963	0.00186	CbGpPWpGaD
Pranlukast—TNF—Adipogenesis—IGF1—hypothyroidism	0.000961	0.00186	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—TSHB—hypothyroidism	0.000942	0.00182	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—TSHR—hypothyroidism	0.000942	0.00182	CbGpPWpGaD
Pranlukast—IL5—Signaling by GPCR—AVP—hypothyroidism	0.000939	0.00182	CbGpPWpGaD
Pranlukast—NFKB1—Integrated Pancreatic Cancer Pathway—IGF1—hypothyroidism	0.000927	0.00179	CbGpPWpGaD
Pranlukast—IL5—Immune System—VAV3—hypothyroidism	0.000891	0.00172	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—CLTC—hypothyroidism	0.000877	0.0017	CbGpPWpGaD
Pranlukast—CYSLTR1—GPCR ligand binding—POMC—hypothyroidism	0.000873	0.00169	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—SH2B3—hypothyroidism	0.000839	0.00162	CbGpPWpGaD
Pranlukast—CYSLTR1—GPCR downstream signaling—VAV3—hypothyroidism	0.000771	0.00149	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—CLTC—hypothyroidism	0.000768	0.00149	CbGpPWpGaD
Pranlukast—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	0.000759	0.00147	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—TRH—hypothyroidism	0.000758	0.00147	CbGpPWpGaD
Pranlukast—CYSLTR1—GPCR downstream signaling—AVP—hypothyroidism	0.000742	0.00144	CbGpPWpGaD
Pranlukast—TNF—Integrated Pancreatic Cancer Pathway—IGF1—hypothyroidism	0.000706	0.00137	CbGpPWpGaD
Pranlukast—NFKB1—Developmental Biology—VAV3—hypothyroidism	0.000704	0.00136	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling by GPCR—VAV3—hypothyroidism	0.0007	0.00135	CbGpPWpGaD
Pranlukast—IL5—GPCR downstream signaling—POMC—hypothyroidism	0.000687	0.00133	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—TSHB—hypothyroidism	0.000676	0.00131	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—TSHR—hypothyroidism	0.000676	0.00131	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling by GPCR—AVP—hypothyroidism	0.000674	0.0013	CbGpPWpGaD
Pranlukast—IL5—Signaling by GPCR—POMC—hypothyroidism	0.000624	0.00121	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—PRL—hypothyroidism	0.000623	0.0012	CbGpPWpGaD
Pranlukast—NFKB1—Innate Immune System—VAV3—hypothyroidism	0.000622	0.0012	CbGpPWpGaD
Pranlukast—CYP2C9—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	0.000616	0.00119	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—SH2B3—hypothyroidism	0.000602	0.00116	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—VAV3—hypothyroidism	0.000576	0.00111	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—AVP—hypothyroidism	0.000555	0.00107	CbGpPWpGaD
Pranlukast—TNF—Developmental Biology—VAV3—hypothyroidism	0.000536	0.00104	CbGpPWpGaD
Pranlukast—ABCC2—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	0.00052	0.001	CbGpPWpGaD
Pranlukast—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	0.000501	0.000968	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—CLTC—hypothyroidism	0.000497	0.00096	CbGpPWpGaD
Pranlukast—CYSLTR1—GPCR downstream signaling—POMC—hypothyroidism	0.000493	0.000954	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling by GPCR—POMC—hypothyroidism	0.000448	0.000866	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—PRL—hypothyroidism	0.000447	0.000864	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—TRH—hypothyroidism	0.000429	0.00083	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—VAV3—hypothyroidism	0.000413	0.000799	CbGpPWpGaD
Pranlukast—ABCC2—Transmembrane transport of small molecules—AVP—hypothyroidism	0.000409	0.000791	CbGpPWpGaD
Pranlukast—CYP3A4—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	0.000406	0.000785	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—AVP—hypothyroidism	0.000398	0.00077	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—PRL—hypothyroidism	0.000391	0.000757	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—IYD—hypothyroidism	0.000386	0.000746	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—TSHB—hypothyroidism	0.000383	0.00074	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—TSHR—hypothyroidism	0.000383	0.00074	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—POMC—hypothyroidism	0.000369	0.000713	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—VAV3—hypothyroidism	0.000362	0.0007	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—IGF1—hypothyroidism	0.000355	0.000686	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—SH2B3—hypothyroidism	0.000341	0.000659	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—ATP5O—hypothyroidism	0.000328	0.000634	CbGpPWpGaD
Pranlukast—CYP2C9—Biological oxidations—POMC—hypothyroidism	0.000327	0.000632	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—TPO—hypothyroidism	0.000308	0.000596	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	0.000286	0.000553	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—POMC—hypothyroidism	0.000265	0.000512	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—IGF1—hypothyroidism	0.000255	0.000492	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—IYD—hypothyroidism	0.000254	0.000492	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—PRL—hypothyroidism	0.000253	0.000489	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—VAV3—hypothyroidism	0.000234	0.000453	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—AVP—hypothyroidism	0.000226	0.000436	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—ATP5O—hypothyroidism	0.000216	0.000418	CbGpPWpGaD
Pranlukast—CYP3A4—Biological oxidations—POMC—hypothyroidism	0.000216	0.000417	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—TPO—hypothyroidism	0.000203	0.000393	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—POMC—hypothyroidism	0.00015	0.00029	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—IGF1—hypothyroidism	0.000144	0.000279	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—TSHB—hypothyroidism	0.000143	0.000276	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—PIK3C2A—hypothyroidism	0.000127	0.000246	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	0.000126	0.000243	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—SLC5A5—hypothyroidism	0.000107	0.000207	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—TSHB—hypothyroidism	9.42e-05	0.000182	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—PIK3C2A—hypothyroidism	8.39e-05	0.000162	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—SLC5A5—hypothyroidism	7.05e-05	0.000136	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—POMC—hypothyroidism	5.59e-05	0.000108	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—POMC—hypothyroidism	3.69e-05	7.13e-05	CbGpPWpGaD
